Europe Prefilled Syringes Market Size, Share & Industry Trends Analysis Report By Application (Diabetes, Anaphylaxis, Rheumatoid Arthritis), By Therapeutics, By Material (Glass-based and Plastic-based), By Design, By Country and Growth Forecast, 2022 - 20

Europe Prefilled Syringes Market Size, Share & Industry Trends Analysis Report By Application (Diabetes, Anaphylaxis, Rheumatoid Arthritis), By Therapeutics, By Material (Glass-based and Plastic-based), By Design, By Country and Growth Forecast, 2022 - 2028

The Europe Prefilled Syringes Market would witness market growth of 10.0% CAGR during the forecast period (2022-2028).

Innovative improvements like buried needles are crucial in the context of self-injection devices in minimizing such injuries, leading to enhanced patient convenience. Prefilled syringes offer security without the increased expense, so their use is anticipated to rise in the coming years. In the coming years, auto-injector use is predicted to increase because to the devices' rising popularity and benefits including patient convenience and low contamination. For example, Owen Mumford Pharmaceutical Services announced its cutting-edge Aidaptus auto-injector platform in July 2021, after the full completion of development.

The two-step, spring-powered Aidaptus auto-injector, which accommodates all 2.25 mL and 1 mL prefilled glass syringes within the same base device, is anticipated to fuel market expansion in the coming years. Over the following years, it is anticipated that the usage of prefilled syringes would increase. Prefilled syringes have several benefits for the pharmaceutical industry, including reducing drug waste, lengthening the life of the product, and boosting market share. For health professionals, prefilled syringes are considered as an effective, dependable and convenient way for drug delivery.

Due to aspects like healthcare professionals' strong preference for prefilled injectable devices to reduce needle-related injuries, the regional market is expanding. Major market companies including SCHOTT group, Haselmeier AG, Stevanato Group, Gerresheimer AG, and Owen Mumford Ltd. are also present in the region. Over time, several businesses have increased their local presence. Due to this circumstance, the market has become more competitive in the region, making it challenging for new competitors to enter.

The Germany market dominated the Europe Prefilled Syringes Market by Country in 2021; thereby, achieving a market value of $921.4 million by 2028. The UK market is estimated to witness a CAGR of 9% during (2022 - 2028). Additionally, The France market would showcase a CAGR of 10.8% during (2022 - 2028).

Based on Application, the market is segmented into Diabetes, Anaphylaxis, Rheumatoid Arthritis, and Others. Based on Therapeutics, the market is segmented into Large Molecules and Small Molecules. Based on Material, the market is segmented into Glass-based and Plastic-based. Based on Design, the market is segmented into Single-chamber, Dual-chamber, and Customized. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Bayer AG, Baxter International, Inc., Becton, Dickinson and Company, Gerresheimer AG, Medtronic PLC, Nipro Corporation, Terumo Corporation, Vetter Pharma, West Pharmaceutical Services, Inc.

Scope of the Study

Market Segments covered in the Report:

By Application

  • Diabetes
  • Anaphylaxis
  • Rheumatoid Arthritis
  • Others
By Therapeutics
  • Large Molecules
  • Small Molecules
By Material
  • Glass-based
  • Plastic-based
By Design
  • Single-chamber
  • Dual-chamber
  • Customized
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Companies Profiled
  • Abbott Laboratories
  • Bayer AG
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Gerresheimer AG
  • Medtronic PLC
  • Nipro Corporation
  • Terumo Corporation
  • Vetter Pharma
  • West Pharmaceutical Services, Inc.
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Prefilled Syringes Market, by Application
1.4.2 Europe Prefilled Syringes Market, by Therapeutics
1.4.3 Europe Prefilled Syringes Market, by Material
1.4.4 Europe Prefilled Syringes Market, by Design
1.4.5 Europe Prefilled Syringes Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.2.5 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. Europe Prefilled Syringes Market by Application
4.1 Europe Diabetes Market by Country
4.2 Europe Anaphylaxis Market by Country
4.3 Europe Rheumatoid Arthritis Market by Country
4.4 Europe Others Market by Country
Chapter 5. Europe Prefilled Syringes Market by Therapeutics
5.1 Europe Large Molecules Market by Country
5.2 Europe Small Molecules Market by Country
Chapter 6. Europe Prefilled Syringes Market by Material
6.1 Europe Glass-based Market by Country
6.2 Europe Plastic-based Market by Country
Chapter 7. Europe Prefilled Syringes Market by Design
7.1 Europe Single-chamber Market by Country
7.2 Europe Dual-chamber Market by Country
7.3 Europe Customized Market by Country
Chapter 8. Europe Prefilled Syringes Market by Country
8.1 Germany Prefilled Syringes Market
8.1.1 Germany Prefilled Syringes Market by Application
8.1.2 Germany Prefilled Syringes Market by Therapeutics
8.1.3 Germany Prefilled Syringes Market by Material
8.1.4 Germany Prefilled Syringes Market by Design
8.2 UK Prefilled Syringes Market
8.2.1 UK Prefilled Syringes Market by Application
8.2.2 UK Prefilled Syringes Market by Therapeutics
8.2.3 UK Prefilled Syringes Market by Material
8.2.4 UK Prefilled Syringes Market by Design
8.3 France Prefilled Syringes Market
8.3.1 France Prefilled Syringes Market by Application
8.3.2 France Prefilled Syringes Market by Therapeutics
8.3.3 France Prefilled Syringes Market by Material
8.3.4 France Prefilled Syringes Market by Design
8.4 Russia Prefilled Syringes Market
8.4.1 Russia Prefilled Syringes Market by Application
8.4.2 Russia Prefilled Syringes Market by Therapeutics
8.4.3 Russia Prefilled Syringes Market by Material
8.4.4 Russia Prefilled Syringes Market by Design
8.5 Spain Prefilled Syringes Market
8.5.1 Spain Prefilled Syringes Market by Application
8.5.2 Spain Prefilled Syringes Market by Therapeutics
8.5.3 Spain Prefilled Syringes Market by Material
8.5.4 Spain Prefilled Syringes Market by Design
8.6 Italy Prefilled Syringes Market
8.6.1 Italy Prefilled Syringes Market by Application
8.6.2 Italy Prefilled Syringes Market by Therapeutics
8.6.3 Italy Prefilled Syringes Market by Material
8.6.4 Italy Prefilled Syringes Market by Design
8.7 Rest of Europe Prefilled Syringes Market
8.7.1 Rest of Europe Prefilled Syringes Market by Application
8.7.2 Rest of Europe Prefilled Syringes Market by Therapeutics
8.7.3 Rest of Europe Prefilled Syringes Market by Material
8.7.4 Rest of Europe Prefilled Syringes Market by Design
Chapter 9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.6 SWOT Analysis
9.2 Medtronic PLC
9.2.1 Company overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.6 SWOT Analysis
9.3 Becton, Dickinson and Company
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Product Launches and Product Expansions:
9.4 Gerresheimer AG
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.5.2 Product Launches and Product Expansions:
9.4.5.3 Acquisition and Mergers:
9.5 West Pharmaceutical Services, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.5.2 Product Launches and Product Expansions:
9.6 Nipro Corporation
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expenses
9.6.5 Recent strategies and developments:
9.6.5.1 Product Launches and Product Expansions:
9.7 Terumo Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Regional Analysis
9.7.5 Recent strategies and developments:
9.7.5.1 Product Launches and Product Expansions:
9.7.5.2 Geographical Expansions:
9.8 Baxter International, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Research & Development Expense
9.9 Bayer AG
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Approvals and Trials:
9.10. Vetter Pharma
9.10.1 Company Overview
9.10.2 Recent strategies and developments:
9.10.2.1 Partnerships, Collaborations, and Agreements:
9.10.2.2 Geographical Expansions:

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings